Stockscreener 앱 받기
5.49
1.48%
0.08
시간 외 거래:
5.49
전일 마감가:
$5.41
열려 있는:
$5.31
하루 거래량:
1.15M
Relative Volume:
0.93
시가총액:
$419.34M
수익:
$83.57M
순이익/손실:
$-4.94M
주가수익비율:
-61.00
EPS:
-0.09
순현금흐름:
$6.97M
1주 성능:
-10.29%
1개월 성능:
-26.80%
6개월 성능:
+102.58%
1년 성능:
+283.92%
1일 변동 폭
$5.25
$5.55
1주일 범위
$5.25
$6.23
52주 변동 폭
$1.36
$7.9738
Chromadex Corp Stock (CDXC) Company Profile
명칭
Chromadex Corp
전화
310-388-6706
주소
10900 WILSHIRE BLVD, LOS ANGELES
CDXC을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CDXC
Chromadex Corp
|
5.49 | 419.34M | 83.57M | -4.94M | 6.97M | -0.07 |
|
KHC
Kraft Heinz Co
|
30.52 | 36.90B | 26.13B | 1.37B | 3.00B | 1.11 |
|
GIS
General Mills Inc
|
63.61 | 35.06B | 19.90B | 2.60B | 2.80B | 4.60 |
|
K
Kellanova Co
|
80.50 | 27.75B | 12.80B | 1.01B | 927.00M | 2.91 |
|
MKC
Mccormick Co Inc
|
78.86 | 21.16B | 6.68B | 792.60M | 774.40M | 2.94 |
|
HRL
Hormel Foods Corp
|
31.68 | 17.39B | 11.92B | 805.04M | 1.01B | 1.46 |
Chromadex Corp Stock (CDXC) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2022-08-16 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2022-08-11 | 다운그레이드 | B. Riley Securities | Buy → Neutral |
| 2022-03-08 | 개시 | ROTH Capital | Buy |
| 2019-10-16 | 개시 | Oppenheimer | Outperform |
| 2019-02-14 | 개시 | B. Riley FBR | Buy |
| 2017-11-27 | 재개 | H.C. Wainwright | Buy |
| 2017-09-25 | 개시 | Ladenburg Thalmann | Buy |
| 2017-01-03 | 개시 | Rodman & Renshaw | Buy |
모두보기
Chromadex Corp 주식(CDXC)의 최신 뉴스
The Manufacturers Life Insurance Company Has $72,000 Position in ChromaDex Co. (NASDAQ:CDXC) - Defense World
ChromaDex (NASDAQ:CDXC) Lowered to Buy Rating by StockNews.com - Defense World
ChromaDex (NASDAQ:CDXC) Lowered to "Buy" Rating by StockNews.com - MarketBeat
ChromaDex appoints Crowe as new auditor - Investing.com
BNP Paribas Financial Markets Increases Position in ChromaDex Co. (NASDAQ:CDXC) - Defense World
Frank L. Jaksch, Jr. Sells 37,161 Shares of ChromaDex Co. (NASDAQ:CDXC) Stock - MarketBeat
Chromadex director Frank Jaksch sells $229,955 in stock - Investing.com
Even though ChromaDex (NASDAQ:CDXC) has lost US$73m market cap in last 7 days, shareholders are still up 389% over 1 year - Yahoo Finance
ChromaDex (NASDAQ:CDXC) Upgraded by StockNews.com to Strong-Buy Rating - Defense World
ChromaDex (CDXC) is on the Move, Here's Why the Trend Could be Sustainable - Yahoo Finance
ChromaDex (NASDAQ:CDXC) Shares Gap UpTime to Buy? - MarketBeat
ChromaDex maintains Buy rating on recent agreement By Investing.com - Investing.com Canada
ChromaDex maintains Buy rating on recent agreement - Investing.com
ChromaDex Named to the Inc. 2024 Best in Business List in the Health Products Category - The Bakersfield Californian
ChromaDex stock soars to 52-week high, hits $7.87 By Investing.com - Investing.com Nigeria
ChromaDex stock soars to 52-week high, hits $7.87 - Investing.com
Tru Niagen’s Canadian retail footprint now includes Whole Foods in Ontario - NutraIngredients-usa.com
ChromaDex Co. (NASDAQ:CDXC) CFO Ozan Pamir Buys 2,907 Shares - MarketBeat
Chromadex CFO Pamir Ozan acquires $21,396 in company stock By Investing.com - Investing.com Australia
Chromadex CFO Pamir Ozan acquires $21,396 in company stock - Investing.com India
Insider Buying: Ozan Pamir Acquires Shares of ChromaDex Corp (CD - GuruFocus.com
ChromaDex (NASDAQ:CDXC) Shares Down 5.5%What's Next? - MarketBeat
ChromaDex Corporation (CDXC) Hits Fresh High: Is There Still Room to Run? - Yahoo Finance
ChromaDex updates equity offering program, adds Roth Capital Partners - Investing.com
ChromaDex updates equity offering program, adds Roth Capital Partners By Investing.com - Investing.com Nigeria
Recent Price Trend in ChromaDex (CDXC) is Your Friend, Here's Why - Yahoo Finance
ChromaDex Gears Up to Report Q3 Earnings: Here's What to Expect - MSN
ChromaDex stock soars to 52-week high, hits $7.58 By Investing.com - Investing.com Australia
ChromaDex stock soars to 52-week high, hits $7.58 - Investing.com
ChromaDex Co. (NASDAQ:CDXC) Short Interest Update - MarketBeat
ChromaDex Expands Niagen IV Access to 200+ Restore Hyper Wellness Clinics - Athletech News
, Featured as the Hero Ingredient in Longevity.Technology’s Inaugural Longevity Supplement - Business Wire
ChromaDex (NASDAQ:CDXC) Sets New 12-Month HighHere's Why - MarketBeat
ChromaDex stock soars to 52-week high, hits $7.08 - Investing.com
ChromaDex (NASDAQ:CDXC) Cut to "Buy" at StockNews.com - MarketBeat
What Makes ChromaDex (CDXC) a Strong Momentum Stock: Buy Now? - Yahoo Finance
ChromaDex rolls out Niagen IV at wellness centers By Investing.com - Investing.com Australia
What is Roth Capital's Estimate for ChromaDex Q2 Earnings? - MarketBeat
ChromaDex rolls out Niagen IV at wellness centers - Investing.com India
ChromaDex's Pharmaceutical-Grade Niagen® IV Now Accessible at over 200 Restore Hyper Wellness Clinics Nationwide - Business Wire
Research Analysts Issue Forecasts for ChromaDex Q4 Earnings - MarketBeat
Shareholders Can Be Confident That ChromaDex's (NASDAQ:CDXC) Earnings Are High Quality - Yahoo Finance
ChromaDex (NASDAQ:CDXC) Hits New 12-Month High After Analyst Upgrade - Defense World
HC Wainwright Issues Positive Outlook for ChromaDex Earnings - MarketBeat
ChromaDex achieves financial stability with strong earnings report, soaring stock price - Natural Products Insider
Chromadex Corp (CDXC) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Chromadex Corp 주식 (CDXC) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Jaksch Frank L Jr | Director |
Dec 13 '24 |
Sale |
6.19 |
37,161 |
229,956 |
244,179 |
2.20%
0.84%
자본화:
|
볼륨(24시간):